Main market
Access this stock data via API
Subscribe
BioInvent International AB
0
0
0%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 198.1M 22.1M 21.4M 12.8M
Cost of revenue
Gross profit
Operating expense
Research & development 144.7M 127.8M 129.3M 107.7M
Selling general and admin 18.4M 17.5M 17.7M 12.8M
Other operating expenses 910K -429K 251K -375K
Operating income 34.1M -122.8M -125.9M -107.3M
Non operating interest income
Income
Expense
Other income expense
Pretax income 38.9M -116.6M -116.8M -97.3M
Tax provision 102K 37K 48K 28K
Net income 38.8M -116.6M -116.9M -97.3M
Basic EPS 0.6 -1.8 -1.8 -1.5
Diluted EPS 0.6 -1.8 -1.8 -1.5
Basic average shares 65.8M 65.9M 65.7M 65.8M
Diluted average shares 65.8M 65.9M 65.7M 65.8M
EBITDA 34.4M -123.9M -130.0M -112.6M
Net income from continuing op. 34.1M -122.8M -125.9M -107.1M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 22 minutes

12:07
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).